Medical College of Wisconsin
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Medical College of Wisconsin sits in the top decile of US sponsors by registered trial count (#79 of 15,742 sponsors by registered trial count).
Medical College of Wisconsin: 447 sponsored US clinical trials, 95 recruiting.
Medical College of Wisconsin sponsors 447 registered US clinical trials on ClinicalTrials.gov, 95 of them currently recruiting, and 236 completed. 28 of these trials are in Phase 3-4 (later-stage) and 129 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 10 trials.
Top-decile sponsor footprint
Medical College of Wisconsin ranks in the top decile of sponsors by registered trial count (#79 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
236 of 286 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
447 total, page 3 of 9
Intensive Postpartum Antihypertensive Treatment
NCT05687344
De-escalated Cyclophosphamide (PTCy) and Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis
NCT05622318
Elimination of Minimal Residual Disease After Transplant
NCT05690984
Immunogenicity of HPV Vaccine in Transplant Recipients.
NCT05557370
Vascular Aging and Lp299v Study
NCT05296395
Loncastuximab Tesirine in Combination With DA-EPOCH-R in Patients With Previously Untreated Aggressive B-cell Lymphoid Malignancies
NCT05270057
Hypofractionated Preoperative Radiation for Head and Neck Cancers (HyPR-HN)
NCT05538533
Oral Gallium Maltolate for the Treatment of Relapsed and Refractory Glioblastoma
NCT04319276
Risk of Metabolic Adaptation After Weight Loss
NCT05139420
Landmark vs. Ultrasound-Assisted Bone Marrow Biopsy Procedure Study
NCT05258357
WI-INTUIT: Bridging Community Based Continence Promotion and Primary Care
NCT05664451
Impact of Lp299v on Vascular Function in Patients With PASC
NCT05227170
Probiotics for Inflammation in Pediatric Chronic Pain
NCT05141890
Renal Metabolism in Salt-sensitive Human Blood Pressure
NCT05369416
Cardiometabolic Health in Transgender Males
NCT04977765
A Study to Measure the Effect of Brain Stimulation on Hand Strength and Function in Patients With Brain Tumors
NCT05023434
Iyengar Yoga for Prolonged Grief Disorder
NCT05026827
The Feasibility and Examination of the Effects of Floatation-based REST on a Community Sample With PTSD
NCT04368689
Analyzing Pulsed Reduced Dose Radiotherapy in Upfront Glioblastoma
NCT04747145
Reducing Innate Inflammation in New Onset Type 1 Diabetes
NCT04335656
Mobilizing Social Network Resources for HIV Care Support
NCT05123274
Preeclampsia Postpartum Antihypertensive Treatment
NCT04298034
Gene Therapy Trial for Platelet Derived Factor VIII Production in Hemophilia A
NCT03818763
Cemiplimab in High-risk or Locally Advanced Luminal and Triple Negative Breast Cancer
NCT04243616
The EndoBARR Trial (Endometrial Bevacizumab, Atezolizumab, Rucaparib)
NCT03694262
Men Moving Forward: A Lifestyle Program for African-American Prostate Cancer Survivors
NCT03971591
Probiotics in Newly Diagnosed T1D
NCT04141761
Increasing PrEP Use in High-Risk Social Networks of African-American MSM in Underserved Low-Risk Cities
NCT03823209
Assessment of Optune Therapy for Patients With Newly Diagnosed Glioblastoma Using Advanced MRI
NCT03297125
Simulation Training in the Pediatric Tracheostomy and Home Ventilator Population
NCT04308109
MRI-Based Preoperative Accelerated Partial Breast Irradiation
NCT02728076
Evaluating the Effects of Genetic Testing on Patients' Stress Levels
NCT02783664
MR Guided Phase II Radiotherapy Dose Escalation in Unresectable Non-Metastatic Pancreatic Cancer
NCT01972919
High-Dose Lymph Node Intensity Modulated Radiation Therapy and Hypofractionated Prostate (SIB)
NCT02177292
Oral Fosamprenavir + Sodium Alginate for GERD
NCT06704100
PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study
NCT05377320
Nemtabrutinib With Venetoclax and Obinutuzumab in Patients With Chronic Lymphocytic Leukemia
NCT07690891
Puerto Rican Obesity Intervention for Men
NCT06440551
Role of Endothelial Dysfunction on Exercise Pressor Reflex in Type 2 Diabetes
NCT07228208
Cancer Lipidome Adaptation and Resculping Through Omega-3 PUFAs in Breast Tumors
NCT07643428
Fully Human Bispecific Anti-CD20, Anti-CD19 CAR T Cells for Patients With Relapsed and/or Refractory B Cell Malignancies
NCT07335328
A Pragmatic Clinical Trial to Prevent Relapse for Myeloid Malignancies With Measurable Disease Prior to Allogeneic Transplant
NCT07572929
A Clinical Trial of the Administration of Light Therapy to Prevent Mouth Sores in Children With Cancer
NCT06623305
BCMA Bispecific Antibody Therapy for Post-BCMA CAR T-Cell Therapy Relapse (RECLAIM)
NCT07009899
Amnioinfusion for Chorioamnionitis: Targeting Neonatal Brain Injury Biomarkers
NCT07610642
Stimulation-based Therapy to Improve Balance in DCM
NCT07298460
Lifestyle, Education, Activity, Nutrition (LEAN) Into Pregnancy
NCT06879054
Fueling Labor: Protein Supplementation for Intrapartum Glucose Control
NCT07571343
Pacritinib in Participants With Metastatic Castrate-Resistant Prostate Cancer That Progressed on or After Prior Treatment With Androgen Receptor Signaling Inhibitors
NCT07226713
FT836 CAR T-cell Therapy in Combination With Daratumumab in Patients With Relapsed and/or Refractory Multiple Myeloma
NCT07221032
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 49 |
| Phase 2 | 80 |
| Phase 3 | 13 |
| Phase 4 | 15 |
Therapeutic Areas
What is open in the Medical College of Wisconsin pipeline
95 recruiting of 447 indexed (21% open); 236 completed (53%).
Phase mix: 28 late (III/IV) vs 129 early (I/II) (early-phase heavy).
Top condition: Stroke (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Medical College of Wisconsin: open-pipeline peers nationwide
Peers matched on 447 registered trials and 21% open enrollment, not the therapeutic-area sidebar.
Medical College of Wisconsin sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 447 trials (± recruiting share)
- Alliance for Clinical Trials in Oncology · 446 trials · 7% recruiting
- University of Virginia · 449 trials · 22% recruiting
- Boston Children's Hospital · 462 trials · 24% recruiting
- Children's Hospital of Philadelphia · 431 trials · 18% recruiting
Sponsors near 21% open enrollment (± trial volume)
- Colorado State University · 21% recruiting · 94 trials
- University of Louisville · 21% recruiting · 217 trials
- Ohio State University · 21% recruiting · 552 trials
- Nova Southeastern University · 21% recruiting · 71 trials
Related
What to do with this Medical College of Wisconsin page
447 registered trials is a research-attention snapshot, not an endorsement of Medical College of Wisconsin or any single study.
- 95 of Medical College of Wisconsin's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Stroke is the condition Medical College of Wisconsin studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Medical College of Wisconsin pipeline card: 447 registered trials from official public datasets.Report a data error.